Abstract: A scanner unit includes, a CIS module having a light source unit, and a CIS which receives reflected light which is emitted in the light source unit; a carriage motor which is provided in the vicinity of the CIS module, and operates along with heat when reading out using the CIS module; a determination unit which determines whether or not dark period measurement data read out using the CIS module in a dark period is in a predetermined range of a reference dark period which is set corresponding to a temperature of the carriage motor; and a control unit which controls the carriage motor so as to limits an operation of the carriage motor in read processing, when the dark period measurement data is not in the range of the reference dark period.

Abstract: To rotate a transport motor and to stop a carriage motor at an ADF reading angle, a control unit outputs a first and a second signal to a first and a second D/A converter, and a power on/off signal to an A-phase driver circuit for the carriage motor. The D/A converters convert the signal to a first and a second voltage. A transport motor driver supplies power to the transport motor on the basis of the first voltage, and a carriage motor driver turns on and off power supply to the A-phase on the basis of the first voltage and the power on/off signal, and supplies power to a B-phase on the basis of the second voltage.

Abstract: A scanner unit includes, a CIS module having a light source unit, and a CIS which receives reflected light which is emitted in the light source unit; a carriage motor which is provided in the vicinity of the CIS module, and operates along with heat when reading out using the CIS module; a determination unit which determines whether or not dark period measurement data read out using the CIS module in a dark period is in a predetermined range of a reference dark period which is set corresponding to a temperature of the carriage motor; and a control unit which controls the carriage motor so as to limits an operation of the carriage motor in read processing, when the dark period measurement data is not in the range of the reference dark period.

Abstract: To rotate a transport motor and to stop a carriage motor at an ADF reading angle, a control unit outputs a first and a second signal to a first and a second D/A converter, and a power on/off signal to an A-phase driver circuit for the carriage motor. The D/A converters convert the signal to a first and a second voltage. A transport motor driver supplies power to the transport motor on the basis of the first voltage, and a carriage motor driver turns on and off power supply to the A-phase on the basis of the first voltage and the power on/off signal, and supplies power to a B-phase on the basis of the second voltage.

Abstract: An apparatus and a method of generating waveforms for driving an ink-jet print head. Waveform data for the overall head-driving waveforms per given unit are written in waveform buffers and then sequentially retrieved at a given timing for analog conversion to obtain an analog head-driving waveform signal. Various head-driving waveforms are thus programmably generated.

Abstract: A driving waveform generating device and method comprises the steps of retaining data on absolute coordinate values in a waveform data storage unit 1 as data at a plurality of points in a plurality of driving waveforms a-f at a predetermined temperature, reading the data on the plurality of point in a desired driving waveform e from a waveform data read unit 3A on the basis of gradation data, correcting the difference between the environmental temperature during the printing operation and the aforesaid predetermined temperature in a temperature compensation unit 3B, converting data on the corrected absolute coordinate value to data on the relative coordinate value in a waveform data conversion unit 3C, interpolating the point-to-point value by means of a waveform data interpolation unit 5, subjecting the interpolated the data on the driving waveform to analog conversion by means of a D/A conversion unit 7, amplifying the analog signal in a signal amplifier unit 9, and outputting the amplified signal.

Abstract: In apparatus and a method of generating waveforms for driving an ink-jet print head, waveform data for the overall head-driving waveforms per given unit are written in waveform buffers BUFFER 0 or BUFFER 1 and then sequentially retrieved at a given timing for analog conversion to obtain an analog head-driving waveform signal. Various head-driving waveforms are thus programmably generated.

Abstract: To provide a vehicle lamp having a high quality lens and a method for manufacturing the same and make it possible to reliably separate a pre-molded lens member while being securely held in the movable die during composite lens molding in a multi-color molding process.

Abstract: A driving waveform generating device and method comprises the steps of retaining data on absolute coordinate values in a waveform data storage unit 1 as data at a plurality of points in a plurality of driving waveforms a-f at a predetermined temperature, reading the data on the plurality of point in a desired driving waveform a from a waveform data read unit 3A on the basis of gradation data, correcting the difference between the environmental temperature during the printing operation and the aforesaid predetermined temperature in a temperature compensation unit 3B, converting data on the corrected absolute coordinate value to data on the relative coordinate value in a waveform data conversion unit 3C, interpolating the point-to-point value by means of a waveform data interpolation unit 5, subjecting the interpolated the data on the driving waveform to analog conversion by means of a D/A conversion unit 7, amplifying the analog signal in a signal amplifier unit 9, and outputting the amplified signal.

Abstract: A driving waveform generating device and method comprises the steps of retaining data on absolute coordinate values in a waveform data storage unit 1 as data at a plurality of points in a plurality of driving waveforms a-f at a predetermined temperature, reading the data on the plurality of point in a desired driving waveform a from a waveform data read unit 3A on the basis of gradation data, correcting the difference between the environmental temperature during the printing operation and the aforesaid predetermined temperature in a temperature compensation unit 3B, converting data on the corrected absolute coordinate value to data on the relative coordinate value in waveform data conversion unit 3C, interpolating the point-to-point value by means of a waveform data interpolation unit 5, subjecting the interpolated the data on the driving waveform to analog conversion by means of a D/A conversion unit 7, amplifying the analog signal in a signal amplifier unit 9, and outputting the amplified signal.

Abstract: Novel cephalosporins which has attached to the exomethylene group at the 3-position of the cephem ring a substituted or unsubstituted aryl, acylamino, aromatic heterocyclic, triazolyl or tetrazolyl group, said aromatic heterocyclic group being attached through a carbon-carbon bond and said triazolyl or tetrazolyl group being attached through a carbon-nitrogen bond, and has the following group attached to the amino group at the 7-position: ##STR1## wherein A represents a group of the formula, --CH.sub.2 -- or a group of the formula ##STR2## in which R.sup.5 represents a hydrogen atom or an alkyl group, and the bond.about.represents syn or anti isomer or their mixture; R.sup.3 represents a hydrogen or halogen atom; and R.sup.4 represents a hydrogen atom or an amino group which may be protected or substituted. These cephalosporins have a broad antibacterial spectrum, are stable against .beta.-lactamase produced by bacteria, have a low toxicity, and are well absorbed when administered orally or parenterally.

Abstract: Novel cephalosporins which has attached to the exomethylene group at the 3-position of the cephem ring a substituted or unsubstituted aryl, acylamino, aromatic heterocyclic, triazolyl or tetrazolyl group, said aromatic heterocyclic group being attached through a carbon-carbon bond and said triazolyl or tetrazolyl group being attached through a carbon-nitrogen bond, and has the following group attached to the amino group at the 7-position: ##STR1## wherein A represents a group of the formula, --CH.sub.2 -- or a group of the formula ##STR2## in which R.sup.5 represents a hydrogen atom or an alkyl group, and the bond represents syn or anti isomer or their mixture; R.sup.3 represents a hydrogen or halogen atom; and R.sup.4 represents a hydrogen atom or an amino group which may be protected or substituted. These cephalosporins have a broad antibacterial spectrum, are stable against .beta.-lactamase produced by bacteria, have a low toxicity, and are well absorbed when administered orally or parenterally.

Abstract: This invention relates to novel 7-(substituted or unsubstituted amino)-3-substituted methyl-.DELTA..sup.3 -cephem-4-carboxylic acids in which a substituted or unsubstituted 1,2,4-triazolyl or 2-(1,2,3,4-tetrazolyl) group attaches to the exomethylene group at the 3-position of the cephem ring through a carbon-nitrogen bond. These cephalosporins are useful intermediates for producing various novel cephalosporins. Also, this invention concerns a process for producing a compound represented by the formula: ##STR1## which comprises reacting a compound represented by the formula: ##STR2## with an optionally substituted triazole or tetrazole in the presence of an acid or a complex of the acid in an organic solvent at 0.degree. to 80.degree. C.

Abstract: Novel cephalosporins which has attached to the exomethylene group at the 3-position of the cephem ring a substituted or unsubstituted aryl, acylamino, aromatic heterocyclic, triazolyl or tetrazolyl group, said aromatic heterocyclic group being attached through a carbon-carbon bond and said triazolyl or tetrazolyl group being attached through a carbon-nitrogen bond, and has the following group attached to the amino group at the 7-position: ##STR1## wherein A represents a group of the formula, --CH.sub.2 -- or a group of the formula ##STR2## in which R.sup.5 represents a hydrogen atom or an alkyl group, and the bond represents syn or anti isomer or their mixture; R.sup.3 represents a hydrogen or halogen atom; and R.sup.4 represents a hydrogen atom or an amino group which may be protected or substituted. These cephalosporins have a broad antibacterial spectrum, are stable against .beta.-lactamase produced by bacteria, have a low toxicity, and are well absorbed when administered orally or parenterally.

Abstract: A 7.alpha.-methoxycephalosporin represented by the general formula: ##STR1## wherein R.sup.1 represents a hydrogen atom or a carboxyl-protecting group; R.sup.2 represents an organic group linked to the carbon atom through an oxygen or sulfur atom; R.sup.3 represents a lower alkyl group; n is 0, 1 or 2; A represents a hydrogen atom or a substituted or unsubstituted alkyl group; and B represents a substituted or unsubstituted alkyl, cycloalkyl, cycloalkenyl, cycloalkadienyl or heterocyclic group, and a salt thereof. These compounds have a broad antibacterial spectrum, high resistance to .beta.-lactamase produced from bacteria, and an effective antibacterial activity against clinical isolates of bacteria.

Abstract: A 7.alpha.-methoxycephalosporin represented by the general formula: ##STR1## wherein R.sup.1 represents a hydrogen atom or a carboxyl-protecting group; R.sup.2 represents an organic group linked to the carbon atom through an oxygen or sulfur atom; R.sup.3 represents a lower alkyl group; n is 0, 1 or 2; A represents a hydrogen atom or a substituted or unsubstituted alkyl group; and B represents a substituted or unsubstituted alkyl, cycloalkyl, cycloalkenyl, cycloalkadienyl or heterocyclic group, and a salt thereof. These compounds have a broad antibacterial spectrum, high resistance to .beta.-lactamase produced from bacteria, and an effective antibacterial activity against clinical isolates of bacteria.

Abstract: A 7.alpha.-methoxycephalosporin represented by the general formula and a salt thereof: ##STR1## wherein R.sup.1 represents a hydrogen atom or a carboxyl-protecting group; R.sup.2 represents an organic group linked to the carbon atoms through an oxygen or sulfur atom; R.sup.3 represents a lower alkyl group; n is 0, 1 or 2; A represents a hydrogen atom or a substituted or unsubstituted alkyl group; and B represents a substituted or unsubstituted alkyl group. These compounds have a broad antibacterial spectrum and high resistance to .beta.-lactamase produced from bacteria, and are well absorbed in a living body.

Abstract: Novel 7.alpha.-methoxy-cephalosporins and non-toxic salts thereof, which contain a di-oxo-piperazinyl-carbonylamino group in molecule. These compounds are valuable antibacterial compounds for use in mammals including man. This disclosure relates to such compounds and methods for producing the same.

Abstract: Novel 7.alpha.-methoxy-cephalosporins and non-toxic salts thereof, which contain a di-oxo-piperazinylcarbonylamino group in molecule. These compounds are valuable antibacterial compounds for use in mammals including man. This disclosure relates to such compounds.